| Dr Kathleen Anne Erwin, MD | |
|
777 Hospital Way, Pocatello, ID 83201-5175 | |
| (208) 239-2571 | |
| (208) 239-3665 |
| Full Name | Dr Kathleen Anne Erwin |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 20 Years |
| Location | 777 Hospital Way, Pocatello, Idaho |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457499113 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | A95835 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pocatello Health Services Llc | 6608927637 | 136 |
News Archive
A new genomics study, led by the Center for Applied Genomics at The Children's Hospital of Philadelphia, sets the stage for the first predictive diagnostic test in a serious immunodeficiency disease in children. If the disorder, common variable immunodeficiency disease, can be diagnosed early, children may receive life-saving treatments before the disease can progress.
Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc. announced that following the regulatory review process by the European Medicines Agency (EMA) and a positive opinion from the Committee for Medicinal Products for Human Use on April 25, 2013, the European Commission (EC) has granted the marketing authorization for XTANDI™ (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.
The preterm birth rate rose again in 2005 and preliminary data for 2006 show a continued increase, underscoring the urgent need for a sustained, comprehensive plan to address this growing crisis.
The survey, released by the National Center for Health Statistics, also found that one in 10 families face medical costs they can't pay at all. Meanwhile, in another development related to the cost of coverage, SunTrust cancels its health plan for Medicare-eligible retirees and is offering them an alternative.
Researchers from the Fred Hutchinson Cancer Research Center in Seattle, WA have taken a closer look at existing mouse models of cancer, specifically comparing them to human cancer samples. These genetically engineered mouse models (which usually either overexpress a cancer-causing gene-or "oncogene"-or carry a deletion for a "tumor suppressor" gene) have been extensively used to understand human cancer biology in studies of drug resistance, early detection, metastasis, and cancer prevention, as well as for the preclinical development of novel targeted therapeutics.
› Verified 6 days ago
| Entity Name | Pocatello Health Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689802852 PECOS PAC ID: 6608927637 Enrollment ID: O20090701000646 |
News Archive
A new genomics study, led by the Center for Applied Genomics at The Children's Hospital of Philadelphia, sets the stage for the first predictive diagnostic test in a serious immunodeficiency disease in children. If the disorder, common variable immunodeficiency disease, can be diagnosed early, children may receive life-saving treatments before the disease can progress.
Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc. announced that following the regulatory review process by the European Medicines Agency (EMA) and a positive opinion from the Committee for Medicinal Products for Human Use on April 25, 2013, the European Commission (EC) has granted the marketing authorization for XTANDI™ (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.
The preterm birth rate rose again in 2005 and preliminary data for 2006 show a continued increase, underscoring the urgent need for a sustained, comprehensive plan to address this growing crisis.
The survey, released by the National Center for Health Statistics, also found that one in 10 families face medical costs they can't pay at all. Meanwhile, in another development related to the cost of coverage, SunTrust cancels its health plan for Medicare-eligible retirees and is offering them an alternative.
Researchers from the Fred Hutchinson Cancer Research Center in Seattle, WA have taken a closer look at existing mouse models of cancer, specifically comparing them to human cancer samples. These genetically engineered mouse models (which usually either overexpress a cancer-causing gene-or "oncogene"-or carry a deletion for a "tumor suppressor" gene) have been extensively used to understand human cancer biology in studies of drug resistance, early detection, metastasis, and cancer prevention, as well as for the preclinical development of novel targeted therapeutics.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kathleen Anne Erwin, MD 777 Hospital Way, Pocatello, ID 83201-5175 Ph: (208) 239-2571 | Dr Kathleen Anne Erwin, MD 777 Hospital Way, Pocatello, ID 83201-5175 Ph: (208) 239-2571 |
News Archive
A new genomics study, led by the Center for Applied Genomics at The Children's Hospital of Philadelphia, sets the stage for the first predictive diagnostic test in a serious immunodeficiency disease in children. If the disorder, common variable immunodeficiency disease, can be diagnosed early, children may receive life-saving treatments before the disease can progress.
Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc. announced that following the regulatory review process by the European Medicines Agency (EMA) and a positive opinion from the Committee for Medicinal Products for Human Use on April 25, 2013, the European Commission (EC) has granted the marketing authorization for XTANDI™ (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.
The preterm birth rate rose again in 2005 and preliminary data for 2006 show a continued increase, underscoring the urgent need for a sustained, comprehensive plan to address this growing crisis.
The survey, released by the National Center for Health Statistics, also found that one in 10 families face medical costs they can't pay at all. Meanwhile, in another development related to the cost of coverage, SunTrust cancels its health plan for Medicare-eligible retirees and is offering them an alternative.
Researchers from the Fred Hutchinson Cancer Research Center in Seattle, WA have taken a closer look at existing mouse models of cancer, specifically comparing them to human cancer samples. These genetically engineered mouse models (which usually either overexpress a cancer-causing gene-or "oncogene"-or carry a deletion for a "tumor suppressor" gene) have been extensively used to understand human cancer biology in studies of drug resistance, early detection, metastasis, and cancer prevention, as well as for the preclinical development of novel targeted therapeutics.
› Verified 6 days ago
Christian F. Schmutz, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1350 Baldy Ave Ste A, Pocatello, ID 83201 Phone: 208-346-7500 Fax: 208-346-7501 | |
Dr. Robert Michael Kennedy, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 777 Hospital Way, G15, Pocatello, ID 83201 Phone: 208-239-2722 Fax: 208-239-3759 | |
Dr. Mary Elizabeth Gerard, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 333 N 18th Ave Ste B4, Pocatello, ID 83201 Phone: 208-232-2233 Fax: 208-232-2299 | |
Dr. William Hazle, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 500 S 11th Ave, Pocatello, ID 83201 Phone: 972-420-8345 Fax: 972-420-7770 | |
Richard D Karem, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 777 Hospital Way, Pocatello, ID 83201 Phone: 208-239-2722 Fax: 208-239-3759 | |
Scott S Petty, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1777 E Clark St, Suite 330, Pocatello, ID 83201 Phone: 208-233-1033 |